Cullen Investment Group, Ltd. Dexcom Inc Transaction History
Cullen Investment Group, Ltd.
- $671 Billion
- Q3 2024
A detailed history of Cullen Investment Group, Ltd. transactions in Dexcom Inc stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 10,888 shares of DXCM stock, worth $747,134. This represents 0.11% of its overall portfolio holdings.
Number of Shares
10,888
Previous 10,434
4.35%
Holding current value
$747,134
Previous $1.18 Billion
38.3%
% of portfolio
0.11%
Previous 0.19%
Shares
3 transactions
Others Institutions Holding DXCM
# of Institutions
1,111Shares Held
364MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.19 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.37 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.12 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.05 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$820 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26.5B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...